Clinical trial of a herbal drug for difficult passage of stools

Phase 2 clinical trial for assessment of safety and efficacy of a multi component botanical formulation SKBISH to relieve constipation

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/01/011251

Enrollment

270

Registered

2018-01-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from constipation

Interventions

Intervention1: SKBISH: Dose: 5.0 Grams Frequency: Every 2-3 Hours Route of administration: Oral Duration of therapy: Minimum 15 days Control Intervention1: Placebo: Dose: 5.0 Grams Frequency: Every 2

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from constipation

Exclusion criteria

Exclusion criteria: Patients not suffering from constipation

Design outcomes

Primary

Measure	Time frame
Relief in constipationTimepoint: 2 days	—

Secondary

Measure	Time frame
Relief in constipationTimepoint: 15 days	—

Countries

India

Contacts

Public ContactAshok Kumar

SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs)

ashok846@gmail.com8126688922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026